当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析 - 现金流量表

昆药集团

(600422)

  

流通市值:66.24亿  总市值:66.24亿
流通股本:7.57亿   总股本:7.57亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,057,275,864.932,094,521,859.34860,540,950.227,160,380,415.16
  收到的税费返还15,966,817.915,780,600.011,795,801.1213,293,571.82
  收到其他与经营活动有关的现金189,879,739.95128,279,787.6927,984,200.79326,873,047.1
  经营活动现金流入小计3,263,122,422.782,238,582,247.04890,320,952.137,500,547,034.08
  购买商品、接受劳务支付的现金2,192,881,262.891,551,076,769.77801,950,371.793,744,966,808.88
  支付给职工以及为职工支付的现金540,677,571.35398,939,356.22242,333,033.06811,455,837.84
  支付的各项税费238,297,564.13199,431,676.37111,277,367.14564,410,153.72
  支付其他与经营活动有关的现金968,216,219.62603,161,821.29348,448,969.862,090,478,130.84
  经营活动现金流出小计3,940,072,617.992,752,609,623.651,504,009,741.857,211,310,931.28
  经营活动产生的现金流量净额-676,950,195.21-514,027,376.61-613,688,789.72289,236,102.8
二、投资活动产生的现金流量:
  收回投资收到的现金2,444,249,824.81,644,249,824.8809,087,644.85,309,344,025.76
  取得投资收益收到的现金15,845,972.7311,081,075.723,559,219.3330,030,603.55
  处置固定资产、无形资产和其他长期资产收回的现金净额1,105,307.04836,697.54395,677.591,781,068.27
  处置子公司及其他营业单位收到的现金净额---4,100,683.22
  投资活动现金流入小计2,461,201,104.571,656,167,598.06813,042,541.725,345,256,380.8
  购建固定资产、无形资产和其他长期资产支付的现金93,856,347.0246,244,714.3632,294,992.0190,559,480.97
  投资支付的现金2,007,000,0001,367,000,000811,000,0005,891,700,000
  投资活动现金流出小计2,100,856,347.021,413,244,714.36843,294,992.015,982,259,480.97
  投资活动产生的现金流量净额360,344,757.55242,922,883.7-30,252,450.29-637,003,100.17
三、筹资活动产生的现金流量:
  吸收投资收到的现金---16,000,000
  其中:子公司吸收少数股东投资收到的现金---16,000,000
  取得借款收到的现金662,905,234.86582,692,436.29241,761,560.451,740,208,570.61
  筹资活动现金流入小计662,905,234.86582,692,436.29241,761,560.451,756,208,570.61
  偿还债务支付的现金814,490,004.93619,324,808.05322,737,897.8853,059,676.43
  分配股利、利润或偿付利息支付的现金161,211,905.3517,705,902.288,975,445.1280,061,700.27
  支付其他与筹资活动有关的现金128,670,252.06124,178,367.735,896,035.331,277,722,717.79
  筹资活动现金流出小计1,104,372,162.34761,209,078.06337,609,378.232,410,844,094.49
  筹资活动产生的现金流量净额-441,466,927.48-178,516,641.77-95,847,817.78-654,635,523.88
四、汇率变动对现金及现金等价物的影响-3,615,210.68-2,931,460.87-1,835,325.48-534,546.4
五、现金及现金等价物净增加额-761,687,575.82-452,552,595.55-741,624,383.27-1,002,937,067.65
  加:期初现金及现金等价物余额1,130,987,344.121,130,987,344.121,130,987,344.122,133,924,411.77
  期末现金及现金等价物余额369,299,768.3678,434,748.57389,362,960.851,130,987,344.12
补充资料:
  净利润--369,694,713.72-419,052,861.68
  资产减值准备-45,417,852.81-31,589,763.74
  固定资产和投资性房地产折旧-52,854,651.91-110,268,016.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,854,651.91-110,268,016.18
  无形资产摊销-26,275,800.47-56,275,723.24
  长期待摊费用摊销-3,720,792.45-8,232,412.94
  处置固定资产、无形资产和其他长期资产的损失--1,175,575.72--673,035.91
  固定资产报废损失-123,471.22--499,982.83
  公允价值变动损失--8,294.49--108,913,808.46
  财务费用-17,307,552.78-50,581,519.23
  投资损失-6,373,078.66--62,011,166.44
  递延所得税--80,443,049.8-41,962,629.53
  其中:递延所得税资产减少--78,370,391.05-41,972,468.58
    递延所得税负债增加--2,072,658.75--9,839.05
  存货的减少--202,146,810.32-149,981,602.92
  经营性应收项目的减少-270,790,871.38-345,144,197.15
  经营性应付项目的增加--364,819,949.87--801,271,508.47
  不涉及现金收支的投资和筹资活动金额其他项目---1,039,406,968.4
  现金的期末余额-678,434,748.57-1,130,987,344.12
  减:现金的期初余额-1,130,987,344.12-2,133,924,411.77
  现金及现金等价物的净增加额--452,552,595.55--1,002,937,067.65
公告日期2026-10-242026-08-222026-04-252026-03-20
审计意见(境内)标准无保留意见
TOP↑